Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Optimal practices for the management of hereditary transthyretin amyloidosis: real-world experience from Japan, Brazil, and Portugal

Fig. 3

Set of practical tests and examinations for monitoring ATTRv amyloidosis progression. aCardiac and ophthalmologic assessments can be scheduled more frequently when any apparent symptoms are observed. ATTRv hereditary transthyretin, BNP brain natriuretic peptide, CMAP compound muscle action potential, COMPASS-31 Composite Autonomic Symptom Score 31, CTS carpal tunnel syndrome, ECG electrocardiography, eGFR estimated glomerular filtration rate, EQ-5D EuroQol 5-dimension, mBMI modified body mass index, NT-proBNP N-terminal pro-brain natriuretic peptide, NYHA New York Heart Association, QoL-DN Quality of Life-Diabetic Neuropathy, SNAP sensory nerve action potential

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172